Genesis Investment Group

Five for Five.
Every Investment Validated.

Five investments made via the Star of Genesis program. Five validated outcomes. A portfolio that materially outperforms top-quartile VC benchmarks.

Portfolio Spotlight

Five Companies.
The Numbers Speak.

Valuations and figures are based on the current fundraising round, derived from financial analysis, market-based comparisons, and asset-based calculations.

Outperforming

NewPhotonics

Invested 2023 · Photonic ICs

A clear fund-maker — invested after over a year of collaboration, supported by strong third-party validation from Leap Fund (Intel alumni). Even under conservative dilution scenarios, the return remains exceptional. This single holding validates early entry, ownership discipline, and a high-conviction strategy.

62.5x Multiple before dilution
Outperforming

OptimalNets

Invested 2025 · AI Networks

Domain-led investment driven by a Genesis member with direct industry expertise. Performing significantly above early expectations with strong indicators across all key metrics. This investment exemplifies Genesis' member-led diligence model — where an insider in the relevant domain leads the evaluation.

10x Multiple before dilution
Outperforming

Spinframe

Invested 2024 · Vehicle Inspection

On-site validation conducted at U.S. ports, including Ashdod Port and ZIM operations. Strong commercial traction with meaningful revenue growth and an expanding client base. A strong example of Genesis' commitment to on-site diligence rather than relying on presentations alone.

5.3x Multiple before dilution
Recovery Phase

Armenta

Invested 2022 · Animal Health

Recently secured strategic funding from an Indian industrial partner, materially strengthening its balance sheet and providing a clear path toward capital recovery in real terms. When a portfolio company faces challenges, the network mobilizes to support recovery rather than writing off the position.

Recovery Strong indicators
Not Executed

BioBeat

Reviewed 2025 · Approved

Approved but ultimately not executed. This outcome represents a notable missed opportunity — the subsequent ~2.5x post-diligence valuation increase further validates the rigor and accuracy of Genesis' sourcing and diligence process. Our diligence was right. Our process worked.

~2.5x Post-diligence increase

Star of Genesis · Upcoming

Innovation in the Pipeline

Genesis' Star of Genesis program regularly presents technology innovation companies to members for evaluation.

AI Platform

Vona

Pre-seed · S/EIS Eligible

An AI-powered storytelling platform building the world's most ambitious archive of the human experience. Transforms personal stories into polished books, eBooks, audiobooks, and podcasts. GDPR compliant and ISO certified. Closing a $350K pre-seed SAFE at a $5M cap.

Nominated

The Fat Company

Food Technology · Genesis Nominated

Produces structured fat from plants that performs identically to animal fat in industrial food production. Same taste, same texture, no reformulation required. Animal fat is a foundational ingredient in a $200B+ global supply chain with few plant-based functional alternatives.

Pipeline opportunities are shared exclusively with Genesis BH members and investors. Information presented is for member reference only.

The Returns Come From the Network

Genesis BH investment access is a member benefit — not a fund product. Access is earned through membership and shaped by the relationships inside the network.

Become a Member